Primary endpoint met in both US trials and positive ex-US EBITDA excl. one-offs in Q4 Fourth quarter 2024Net sales for the quarter totalled MSEK 49.2 (44.5), equivalent to an increase of 10% compared ...
SEMINOLE, FL / ACCESS Newswire / February 12, 2025 / For many, visiting the dentist can be a stressful and overwhelming ...
Sedana Medical AB (publ) announces that its second pivotal US trial INSPiRE-ICU 2 has met its primary endpoint, and hence established non-inferiority of inhaled sedation with isoflurane compared with ...
The new year is the perfect time to set new health goals and make appointments to take care of yourself and your family’s health needs, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results